Thrombin Generation Assay
TGA is a universal test capable of assessing a research subject’s global hemostatic balance by measuring the overall tendency of a plasma sample to form thrombin after the initiation of coagulation. In the case of a drug product the TGA is applied to identify the factor XIa-like, pro-coagulant activity in the IVIG or other plasma-derived therapeutic. In this way, the thrombogenic potential of these drugs can be measured thus enabling manufacturers to increase the safety of their drug product, and to satisfy regulatory requirements.NAPTT Assay
This method is the most general coagulation test used to implicate the presence of any contaminating active coagulation factors, and can be used to test the final product for thrombogenicity or possibly for trouble-shooting in purification stages. When run using FXI deficient plasma the NAPTT will show evidence of unusually-high FXI/XIa activity in your sample.Chromogenic Assay
We can measure factor XIa activity in your IVIG using a commercially available, chromogenic factor XIa assay kit. A chromogenic assay provides a sensitive and specific quantitative activity determination of contaminating factor XIa in highly purified protein preparations such as IVIG.
To Learn More
Contact us using the form on the right or call us at +1 (802) 878-1777 to learn more about how we can assist you with characterizing your IVIG drug product.
